News Novo hopes data will boost new insulin in US and Germany Novo Nordisk hopes that new data supporting the cardiovascular and glycaemic safety of its Tresiba long-acting insulin will prove a game-changer in the US.
News Pharma hires Theresa May's former adviser to head government... Saratha Rajeswaran will lead government affairs team
News FDA's Gottlieb reveals plans to tackle generic price abuses Tackling high drug prices is priority for Trump administrations.
News UK watchdog says MSD may have blocked Remicade biosimilars MSD may have abused dominant market position, says CMA.
News EU probes Aspen price gouging allegations Aspen pulled drugs from some countries that rejected price hikes, says EU.
News US authorities probe marketing of J&J drugs US authorities suspicious over marketing, rebates and payment support programmes.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.